Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.

Article  PubMed  PubMed Central  Google Scholar 

Masui T, Ito T, Komoto I, Uemoto S, Group JPS. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. BMC Cancer. 2020;20(1):1104.

Article  PubMed  PubMed Central  Google Scholar 

Masui T, Ito T, Komoto I, Kojima S, Kasai Y, Tanabe M, Hara K, Hirano S, Okusaka T, Ichikawa Y, et al. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan. Int J Clin Oncol. 2022;27(5):840–9.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Z, Chen C, Jiang L, Zhou X, Dai X, Song Y, Li Y. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: a population-based study. Cancer Med. 2019;8(17):7288–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Song J, Liu P, Mazid MA, Lu L, Shang Y, Wei Y, Gong P, Ma L. A modified M-stage classification based on the metastatic patterns of pancreatic neuroendocrine neoplasms: a population-based study. BMC Endocr Disord. 2018;18(1):73.

Article  PubMed  PubMed Central  Google Scholar 

Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010;17(12):3129–36.

Article  PubMed  Google Scholar 

Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, et al. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2020;121(2):330–6.

Article  PubMed  Google Scholar 

Ruzzenente A, Bagante F, Bertuzzo F, Aldrighetti L, Campagnaro T, Ercolani G, Conci S, Giuliante F, Dore A, Ferrero A, et al. Liver resection for neuroendocrine tumor liver metastases within Milan criteria for liver transplantation. J Gastrointest Surg. 2019;23(1):93–100.

Article  PubMed  Google Scholar 

Gudmundsdottir H, Habermann EB, Vierkant RA, Starlinger P, Thiels CA, Warner SG, Smoot RL, Truty MJ, Kendrick ML, Halfdanarson TR, et al. Survival and symptomatic relief after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: long-term follow-up evaluation of more than 500 patients. Ann Surg Oncol. 2023;30(8):4840–51.

Article  PubMed  PubMed Central  Google Scholar 

Pavel M, O’Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E, Knigge U, Salazar R, Pape UF, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103(2):172–85.

Article  CAS  PubMed  Google Scholar 

Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, et al. The Surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46(6):715–31.

Article  PubMed  PubMed Central  Google Scholar 

Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, Minter RM, Lairmore TC, Tseng JF, Zeh HJ, et al. The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(1):1–33.

Article  PubMed  PubMed Central  Google Scholar 

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf.

Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Nakajima TE, et al. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci. 2021;28(1):1–25.

Article  CAS  PubMed  Google Scholar 

Aoki T, Kubota K, Kiritani S, Arita J, Morizane C, Masui T, Kudo A, Komoto I, Hatano E, Ito T, et al. Survey of surgical resections for neuroendocrine liver metastases: a project study of the Japan Neuroendocrine Tumor Society (JNETS). J Hepatobiliary Pancreat Sci. 2021;28(6):489–97.

Article  PubMed  Google Scholar 

Le Treut YP, Grégoire E, Belghiti J, Boillot O, Soubrane O, Mantion G, Cherqui D, Castaing D, Ruszniewski P, Wolf P, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant. 2008;8(6):1205–13.

Article  PubMed  Google Scholar 

Gedaly R, Daily MF, Davenport D, McHugh PP, Koch A, Angulo P, Hundley JC. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg. 2011;146(8):953–8.

Article  PubMed  Google Scholar 

Nguyen NT, Harring TR, Goss JA, O’Mahony CA. Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience. Int J Hepatol. 2011;2011: 742890.

Article  PubMed  PubMed Central  Google Scholar 

Le Treut YP, Grégoire E, Klempnauer J, Belghiti J, Jouve E, Lerut J, Castaing D, Soubrane O, Boillot O, Mantion G, et al. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg. 2013;257(5):807–15.

Article  PubMed  Google Scholar 

Sher LS, Levi DM, Wecsler JS, Lo M, Petrovic LM, Groshen S, Ji L, Uso TD, Tector AJ, Hamilton AS, et al. Liver transplantation for metastatic neuroendocrine tumors: outcomes and prognostic variables. J Surg Oncol. 2015;112(2):125–32.

Article  PubMed  PubMed Central  Google Scholar 

Nobel YR, Goldberg DS. Variable use of model for end-stage liver disease exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes. Transplantation. 2015;99(11):2341–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Houben P, Schimmack S, Unterrainer C, Döhler B, Mehrabi A, Süsal C. Rare malignant indications for liver transplantation: a collaborative transplant study report. Front Surg. 2021;8: 678392.

Article  PubMed  PubMed Central  Google Scholar 

Valvi D, Mei X, Gupta M, Shah MB, Ancheta A, Marti F, Gedaly R. Younger age is associated with improved survival in patients undergoing liver transplantation alone for metastatic neuroendocrine tumors. J Gastrointest Surg. 2021;25(6):1487–93.

Article  PubMed  Google Scholar 

Eshmuminov D, Studer DJ, Lopez Lopez V, Schneider MA, Lerut J, Lo M, Sher L, Musholt TJ, Lozan O, Bouzakri N, et al. Controversy over liver transplantation or resection for neuroendocrine liver metastasis: tumor biology cuts the deal. Ann Surg. 2023;277(5):e1063–71.

Article  PubMed  Google Scholar 

Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol. 2007;47(4):460–6.

Article  PubMed  Google Scholar 

Mazzaferro V, Sposito C, Coppa J, Miceli R, Bhoori S, Bongini M, Camerini T, Milione M, Regalia E, Spreafico C, et al. The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors. Am J Transplant. 2016;16(10):2892–902.

Article  CAS  PubMed  Google Scholar 

Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, et al. Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society. Hepatol Res. 2019;49(9):964–80.

Article  PubMed  Google Scholar 

Eguchi S, Umeshita K, Soejima Y, Eguchi H, Egawa H, Fukumoto T, Haga H, Hasegawa K, Kasahara M, Nagano H, et al. An analysis of 10,000 cases of living donor liver transplantation in Japan: special reference to the graft-versus-recipient weight ratio and donor age. Ann Surg. 2024;279(1):94–103.

Article  PubMed  Google Scholar 

Maspero M, Rossi RE, Sposito C, Coppa J, Citterio D, Mazzaferro V. Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria. Am J Transplant. 2022;22(11):2598–607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol. 2009;27(28):4656–63.

Article  CAS  PubMed